Stay updated with breaking news from Fraction Ablative Stereotactic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced, in recognition of Pancreatic Cancer Awareness Month, more than 2,300 pancreatic cancer patients...
/PRNewswire/ -- ViewRay, Inc. (NASDAQ: VRAY) today announced that the results of a multi-center study of 148 inoperable pancreatic cancer patients treated with...
Findings show median overall survival of 26 months for patients receiving ablative doses with MRIdian MRI-guided radiation therapy